Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 46

1.

Murine Cytomegalovirus Spread Depends on the Infected Myeloid Cell Type.

Farrell HE, Bruce K, Lawler C, Stevenson PG.

J Virol. 2019 Jul 17;93(15). pii: e00540-19. doi: 10.1128/JVI.00540-19. Print 2019 Aug 1.

PMID:
31092580
2.

Cytomegalovirus host entry and spread.

Farrell HE, Stevenson PG.

J Gen Virol. 2019 Apr;100(4):545-553. doi: 10.1099/jgv.0.001230. Epub 2019 Feb 7.

PMID:
30730289
3.

Murine Cytomegalovirus Glycoprotein O Promotes Epithelial Cell Infection In Vivo.

Yunis J, Farrell HE, Bruce K, Lawler C, Wyer O, Davis-Poynter N, Brizić I, Jonjić S, Adler B, Stevenson PG.

J Virol. 2019 Jan 17;93(3). pii: e01378-18. doi: 10.1128/JVI.01378-18. Print 2019 Feb 1.

4.

Human cytomegalovirus US28 allows dendritic cell exit from lymph nodes.

Farrell HE, Bruce K, Ma J, Davis-Poynter N, Stevenson PG.

J Gen Virol. 2018 Nov;99(11):1509-1514. doi: 10.1099/jgv.0.001154. Epub 2018 Sep 18.

PMID:
30226462
5.

Murine cytomegalovirus degrades MHC class II to colonize the salivary glands.

Yunis J, Farrell HE, Bruce K, Lawler C, Sidenius S, Wyer O, Davis-Poynter N, Stevenson PG.

PLoS Pathog. 2018 Feb 15;14(2):e1006905. doi: 10.1371/journal.ppat.1006905. eCollection 2018 Feb.

6.

Murine Cytomegalovirus Spreads by Dendritic Cell Recirculation.

Farrell HE, Bruce K, Lawler C, Oliveira M, Cardin R, Davis-Poynter N, Stevenson PG.

MBio. 2017 Oct 3;8(5). pii: e01264-17. doi: 10.1128/mBio.01264-17.

7.

Type 1 Interferons and NK Cells Limit Murine Cytomegalovirus Escape from the Lymph Node Subcapsular Sinus.

Farrell HE, Bruce K, Lawler C, Cardin RD, Davis-Poynter NJ, Stevenson PG.

PLoS Pathog. 2016 Dec 7;12(12):e1006069. doi: 10.1371/journal.ppat.1006069. eCollection 2016 Dec.

8.
9.

Murine Cytomegalovirus Exploits Olfaction To Enter New Hosts.

Farrell HE, Lawler C, Tan CS, MacDonald K, Bruce K, Mach M, Davis-Poynter N, Stevenson PG.

MBio. 2016 Apr 26;7(2):e00251-16. doi: 10.1128/mBio.00251-16.

10.

Alveolar Macrophages Are a Prominent but Nonessential Target for Murine Cytomegalovirus Infecting the Lungs.

Farrell HE, Lawler C, Oliveira MT, Davis-Poynter N, Stevenson PG.

J Virol. 2015 Dec 30;90(6):2756-66. doi: 10.1128/JVI.02856-15.

11.

Lymph Node Macrophages Restrict Murine Cytomegalovirus Dissemination.

Farrell HE, Davis-Poynter N, Bruce K, Lawler C, Dolken L, Mach M, Stevenson PG.

J Virol. 2015 Jul;89(14):7147-58. doi: 10.1128/JVI.00480-15. Epub 2015 Apr 29.

12.

Virus-encoded 7 transmembrane receptors.

Mølleskov-Jensen AS, Oliveira MT, Farrell HE, Davis-Poynter N.

Prog Mol Biol Transl Sci. 2015;129:353-93. doi: 10.1016/bs.pmbts.2014.10.010. Epub 2014 Dec 24. Review.

PMID:
25595810
13.

Identification of common mechanisms by which human and mouse cytomegalovirus seven-transmembrane receptor homologues contribute to in vivo phenotypes in a mouse model.

Farrell HE, Abraham AM, Cardin RD, Mølleskov-Jensen AS, Rosenkilde MM, Davis-Poynter N.

J Virol. 2013 Apr;87(7):4112-7. doi: 10.1128/JVI.03406-12. Epub 2013 Jan 23.

14.

Partial functional complementation between human and mouse cytomegalovirus chemokine receptor homologues.

Farrell HE, Abraham AM, Cardin RD, Sparre-Ulrich AH, Rosenkilde MM, Spiess K, Jensen TH, Kledal TN, Davis-Poynter N.

J Virol. 2011 Jun;85(12):6091-5. doi: 10.1128/JVI.02113-10. Epub 2011 Apr 13.

15.

The M33 chemokine receptor homolog of murine cytomegalovirus exhibits a differential tissue-specific role during in vivo replication and latency.

Cardin RD, Schaefer GC, Allen JR, Davis-Poynter NJ, Farrell HE.

J Virol. 2009 Aug;83(15):7590-601. doi: 10.1128/JVI.00386-09. Epub 2009 May 13.

16.

Analysis of the subcellular trafficking properties of murine cytomegalovirus M78, a 7 transmembrane receptor homologue.

Sharp EL, Davis-Poynter NJ, Farrell HE.

J Gen Virol. 2009 Jan;90(Pt 1):59-68. doi: 10.1099/vir.0.004853-0.

PMID:
19088273
17.

Functional analysis of the murine cytomegalovirus chemokine receptor homologue M33: ablation of constitutive signaling is associated with an attenuated phenotype in vivo.

Case R, Sharp E, Benned-Jensen T, Rosenkilde MM, Davis-Poynter N, Farrell HE.

J Virol. 2008 Feb;82(4):1884-98. Epub 2007 Dec 5.

18.

Sequence analysis of the equid herpesvirus 2 chemokine receptor homologues E1, ORF74 and E6 demonstrates high sequence divergence between field isolates.

Sharp EL, Farrell HE, Borchers K, Holmes EC, Davis-Poynter NJ.

J Gen Virol. 2007 Sep;88(Pt 9):2450-62.

PMID:
17698654
19.

Function of CMV-encoded MHC class I homologues.

Farrell HE, Davis-Poynter NJ, Andrews DM, Degli-Esposti MA.

Curr Top Microbiol Immunol. 2002;269:131-51. Review.

PMID:
12224506
20.

NK1.1+ cells and murine cytomegalovirus infection: what happens in situ?

Andrews DM, Farrell HE, Densley EH, Scalzo AA, Shellam GR, Degli-Esposti MA.

J Immunol. 2001 Feb 1;166(3):1796-802.

21.

Techniques for studying murine natural killer cells in defense against viral infection.

Scalzo AA, Farrell HE, Karupiah G.

Methods Mol Biol. 2000;121:163-77. Review. No abstract available.

PMID:
10818725
22.

Murine cytomegalovirus homologues of cellular immunomodulatory genes.

Davis-Poynter NJ, Degli-Esposti M, Farrell HE.

Intervirology. 1999;42(5-6):331-41. Review.

PMID:
10702715
23.

m144, a murine cytomegalovirus (MCMV)-encoded major histocompatibility complex class I homologue, confers tumor resistance to natural killer cell-mediated rejection.

Cretney E, Degli-Esposti MA, Densley EH, Farrell HE, Davis-Poynter NJ, Smyth MJ.

J Exp Med. 1999 Aug 2;190(3):435-44.

24.

Transcriptional analysis of the murine cytomegalovirus HindIII-I region: identification of a novel immediate-early gene region.

Hanson LK, Dalton BL, Karabekian Z, Farrell HE, Rawlinson WD, Stenberg RM, Campbell AE.

Virology. 1999 Jul 20;260(1):156-64.

25.

Cytomegalovirus evasion of natural killer cell responses.

Farrell HE, Degli-Esposti MA, Davis-Poynter NJ.

Immunol Rev. 1999 Apr;168:187-97. Review.

PMID:
10399075
26.

Inhibition of NK cells by murine CMV-encoded class I MHC homologue m144.

Kubota A, Kubota S, Farrell HE, Davis-Poynter N, Takei F.

Cell Immunol. 1999 Feb 1;191(2):145-51.

PMID:
9973537
27.

From sabotage to camouflage: viral evasion of cytotoxic T lymphocyte and natural killer cell-mediated immunity.

Farrell HE, Davis-Poynter NJ.

Semin Cell Dev Biol. 1998 Jun;9(3):369-78. Review.

PMID:
9705659
28.

The murine cytomegalovirus (MCMV) homolog of the HCMV phosphotransferase (UL97(pk)) gene.

Rawlinson WD, Zeng F, Farrell HE, Cunningham AL, Scalzo AA, Booth TW, Scott GM.

Virology. 1997 Jul 7;233(2):358-63.

29.

Inhibition of natural killer cells by a cytomegalovirus MHC class I homologue in vivo.

Farrell HE, Vally H, Lynch DM, Fleming P, Shellam GR, Scalzo AA, Davis-Poynter NJ.

Nature. 1997 Apr 3;386(6624):510-4.

PMID:
9087412
30.

Identification and characterization of a G protein-coupled receptor homolog encoded by murine cytomegalovirus.

Davis-Poynter NJ, Lynch DM, Vally H, Shellam GR, Rawlinson WD, Barrell BG, Farrell HE.

J Virol. 1997 Feb;71(2):1521-9.

31.

Masters of deception: a review of herpesvirus immune evasion strategies.

Davis-Poynter NJ, Farrell HE.

Immunol Cell Biol. 1996 Dec;74(6):513-22. Review.

PMID:
8989589
32.

Analysis of the complete DNA sequence of murine cytomegalovirus.

Rawlinson WD, Farrell HE, Barrell BG.

J Virol. 1996 Dec;70(12):8833-49.

34.

Murine cytomegalovirus with a deletion of genes spanning HindIII-J and -I displays altered cell and tissue tropism.

Cavanaugh VJ, Stenberg RM, Staley TL, Virgin HW 4th, MacDonald MR, Paetzold S, Farrell HE, Rawlinson WD, Campbell AE.

J Virol. 1996 Mar;70(3):1365-74.

35.

DNA sequence and transcriptional analysis of the glycoprotein M gene of murine cytomegalovirus.

Scalzo AA, Forbes CA, Davis-Poynter NJ, Farrell HE, Lyons PA.

J Gen Virol. 1995 Nov;76 ( Pt 11):2895-901.

PMID:
7595401
36.

Identification, sequencing and expression of the glycoprotein L gene of murine cytomegalovirus.

Xu J, Scalzo AA, Lyons PA, Farrell HE, Rawlinson WD, Shellam GR.

J Gen Virol. 1994 Nov;75 ( Pt 11):3235-40.

PMID:
7964634
38.

A murine cytomegalovirus-neutralizing monoclonal antibody exhibits autoreactivity and induces tissue damage in vivo.

Chapman AJ, Farrell HE, Thomas JA, Papadimitriou JM, Garlepp MJ, Scalzo AA, Shellam GR.

Immunology. 1994 Mar;81(3):435-43.

39.

Vaccine potential of a herpes simplex virus type 1 mutant with an essential glycoprotein deleted.

Farrell HE, McLean CS, Harley C, Efstathiou S, Inglis S, Minson AC.

J Virol. 1994 Feb;68(2):927-32.

40.

Molecular and biological characterization of new strains of murine cytomegalovirus isolated from wild mice.

Booth TW, Scalzo AA, Carrello C, Lyons PA, Farrell HE, Singleton GR, Shellam GR.

Arch Virol. 1993;132(1-2):209-20.

PMID:
8102523
41.

Murine anti-cytomegalovirus monoclonal antibodies with autoreactivity.

Lawson CM, O'Donoghue HL, Farrell HE, Shellam GR, Reed WD.

Immunology. 1991 Mar;72(3):426-33.

42.
43.

Characterization of neutralizing monoclonal antibodies to murine cytomegalovirus.

Farrell HE, Shellam GR.

J Gen Virol. 1990 Mar;71 ( Pt 3):655-64.

PMID:
2155998
44.
45.

The genetic background modulates the effect of the beige gene on susceptibility to cytomegalovirus infection in mice.

Shellam GR, Flexman JP, Farrell HE, Papadimitriou JM.

Scand J Immunol. 1985 Aug;22(2):147-55.

PMID:
2412279
46.

Regulation of natural killer cell activity and interferon production in the rat lung following aerosol challenge.

Farrell HE, Holt PG, Shellam GR.

Int Arch Allergy Appl Immunol. 1985;78(3):318-25.

PMID:
2414231

Supplemental Content

Loading ...
Support Center